Vimarsana
Biggest News Aggregation in the World

Page 2 - Analytical Validation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analytical Validation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analytical Validation Today - Breaking & Trending Today

Consistent And Clear Terminology Best Practices Needed To Scale Sensor-Based DHTs - Vimarsana News

Consistent And Clear Terminology Best Practices Needed To Scale Sensor-Based DHTs

Sensor-based digital health technologies (DHTs) have been increasingly adopted in clinical research, clinical care, and everyday life, but a lack of...

Digital Medicine Society (DiMe): Digital Health Leaders Align on Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis - Vimarsana News

Digital Medicine Society (DiMe): Digital Health Leaders Align on Nocturnal Scratch as a Digital Endpoint for Atopic Dermatitis

BOSTON, Sept. 8, 2022 /PRNewswire/ -- The Digital Medicine Society (DiMe) has released a new set of resources to advance the use of digitally measured nocturnal scratch as a meaningful endpoint

Aspira Women's Health Hosting Women's Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay - Vimarsana News

Aspira Women's Health Hosting Women's Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay

AUSTIN, Texas, Aug. 18, 2022 -- Aspira Women’s Health Inc. , a bio-analytical based women’s health company focused on gynecologic disease, today announced that it will host a key... | August 18, 2022

Aspira Women's Health Reports Second Quarter 2022 Financial - Vimarsana News

Aspira Women's Health Reports Second Quarter 2022 Financial

Increased product revenue by 17% to $2.0 million; Grew OVA1plus volume by 19% to 5,411 units Entered into a research agreement with Harvard’s Dana Farber...

Aspira Women's Health Reports Second Quarter 2022 Financial Results - Vimarsana News

Aspira Women's Health Reports Second Quarter 2022 Financial Results

10.08.2022 - Increased product revenue by 17% to $2.0 million; Grew OVA1plus volume by 19% to 5,411 units Entered into a research agreement with Harvard’s Dana Farber Cancer Institute, Brigham & Women’s Hospital, and Medical University of Lodz for development ...